SUNY

Campaign to Repeal New York's Multibillion Dollar Stock Transfer Tax Rebate Takes Aim at Governor Hochul, Legislators and Corporate Naysayers

Retrieved on: 
星期二, 三月 12, 2024
Transfer, Homelessness, SUNY, Letter, Assembly, Sanitation, Tax, STT, Education, CBC, Common, School, Political campaign staff, Sleep, STTR, Security, Sale, Transport, Student, Crime, CUNY, Housing, NYS, New Yorker, Campaign, Cat, Book, Firefighter, DSM-IV codes, Coalition for the Homeless, Sadness, Senate, State, Legislation, Police, Cryptocurrency

Their responses will be tabulated and reported on the Campaign's website GreedvsNeed.org describing if they "Support Greed" or "Support Need."

Key Points: 
  • Their responses will be tabulated and reported on the Campaign's website GreedvsNeed.org describing if they "Support Greed" or "Support Need."
  • Nonresponders will be tabulated as supporting greed and will be publicly admonished and become the focus of the statewide Greed V$ Need Campaign.
  • From 1905 to 1981, New York State collected a tiny one-tenth of one percent tax called the Stock Transfer Tax (STT) on the sale of corporate stocks.
  • Some leading legislators are saying, "Now is not the right time to repeal the STTR."

StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast

Retrieved on: 
星期四, 二月 29, 2024
Pet, Anxiety, Parkinson's disease, Intelligence, Traction, Chemical oxygen demand, DSM-IV codes, Quality of life, Cancer, MIT, Pain, OTC Markets Group, State, Database, Cannabinoid, State university system, International Cannabinoid Research Society, Chronic pain, Business, SUNY, Depression, CBD, Patient, Medicine, Osteoarthritis, Pharmacotherapy, Movement, Interview, Insomnia, Cannabis, Research, Alzheimer's disease

I financed and worked with Olivia Newton-John's Koala Blue in the 1980's and Richard Diehl's Graphsoft (now Vectorworks) in the 1990's.

Key Points: 
  • I financed and worked with Olivia Newton-John's Koala Blue in the 1980's and Richard Diehl's Graphsoft (now Vectorworks) in the 1990's.
  • I developed regenerative medicine systems with stem cell technology in the 1980's working on umbilical cord therapy to treat genetic diseases, cancers, and inherited disorders.
  • In 2024 we will focus our efforts on the development of our upcoming advanced AI app and our CBD brand that will expand into many products.
  • We will seek to forge a new path in our approach to healthcare, that will expand to CBD products for pets as well as a nutritional app.

AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors

Retrieved on: 
星期三, 二月 28, 2024
Research, Doctor of Philosophy, General partnership, Drug development, Growth, Frustration, University, Chronic pain, SUNY, Biomedical sciences, Epilepsy, Neurology, Rett syndrome, Smith, Kline & French, Acadia Pharmaceuticals, School, University at Buffalo, Biotechnology, ATyr Pharma, Health, Neurotoxicity, Cell, Therapy, DSM-IV codes, Brain, Neuropharmacology, Proteostasis, Amathus, Record, Drug discovery, Peripheral neuropathy, MPS, Physics, OPKO Health, Genomics, Acquisition, EMD, LoDo, Denver, MD, Organoid, Multiple sclerosis, Prevalence, Brown University, Brandeis University, Serono, Patient, Disease, GSK plc, Pharmaceutical industry

Dr. Pfost noted, “AxoSim embodies the entrepreneur’s sweet spot--when market need, technological innovation, timing and team all align. The growing prevalence of neurological diseases places enormous burdens on patients, their families and society. Yet despite billions in investment, neurology R&D continues to disappoint. AxoSim’s transformational approach addresses a key contributor to these failures—the lack of relevant disease models—by providing functional human data from its microphysiological system (MPS) organoid technologies early in the process. AxoSim aims to become an industry leader in helping to deliver urgently needed new drugs and I welcome the opportunity to contribute to its success.”

Key Points: 
  • Dr. Pfost and Dr. Weiner have decades of experience in building successful biotechnology companies spanning therapeutics, diagnostics and life science tools and technologies.
  • “Our recent acquisition of a third platform technology positions AxoSim for growth, and we are fortunate to have these two talented industry veterans assuming key leadership roles,” said Lowry Curley, PhD, co-founder and Chief Executive Officer of AxoSim.
  • “Dale and Dave bring successful track records in building life sciences businesses, with broad and complementary skill sets.
  • Dale’s work in life science tools and venture finance is highly relevant, as is Dave’s expertise in leading neurological drug discovery and clinical development.

RS BioTherapeutics Creates Therapeutic Expert Council to Provide Guidance on Development of First-in-Class Agent Focused on Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

Retrieved on: 
星期三, 二月 21, 2024
TEC, IPF, University, Idiopathic disease, Division, Assistant, Critical care, Idiopathic pulmonary fibrosis, Chronic obstructive pulmonary disease, Clinical research, Outline of health sciences, Consultant, Respiratory Medicine, Death, SUNY, Observation, Harvard Medical School, COPD, Pharmaceutical industry

CUMBERLAND, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce the formation of its Therapeutic Expert Council (TEC).

Key Points: 
  • CUMBERLAND, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce the formation of its Therapeutic Expert Council (TEC).
  • The TEC will help guide the development of RS BioTherapeutics’ first-in-class, steroid-free agent, RSBT-001, in development for Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of death in the world; and Idiopathic Pulmonary Fibrosis (IPF), a rare disease with no cure that claims 40,000 lives each year in the U.S.
  • All have exceptional credentials and are uniquely qualified to help support the development of our first investigational compound, RSBT-001.
  • I’m excited to collaborate with them and look forward to engaging their diverse perspectives spanning the fields of COPD, IPF, and other diseases characterized by pulmonary inflammation.”

GlobalFoundries and Biden-Harris Administration Announce CHIPS and Science Act Funding for Essential Chip Manufacturing

Retrieved on: 
星期一, 二月 19, 2024
CHIPS, General Motors, Research, GameChanger, Empire, Education, Investment, News, Upstate, Growth, Commerce, Qualcomm, University, ITC, SUNY, Lockheed Martin, Energy, Century, Semiconductor, Workforce, Student, GlobalFoundries, Electronics, GM, White, Economic development, AMD, Ecosystem, HVCC, Partnership, Hudson Valley Community College, Learning, Economy, NYPA, Gallium nitride, Capital, Chair, Science, GFS, AI, Internet of things, Government, COVID-19, Lockheed, Empire State, Renewable energy

MALTA, N.Y. and ESSEX JUNCTION, Vt., Feb. 19, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Commerce today announced $1.5 billion in planned direct funding for GlobalFoundries (Nasdaq: GFS) (GF) as part of the U.S. CHIPS and Science Act. This investment will enable GF to expand and create new manufacturing capacity and capabilities to securely produce more essential chips for automotive, IoT, aerospace, defense, and other vital markets.

Key Points: 
  • This investment will enable GF to expand and create new manufacturing capacity and capabilities to securely produce more essential chips for automotive, IoT, aerospace, defense, and other vital markets.
  • GF is the first semiconductor pure play foundry to receive a major award (over $1.5 billion) from the CHIPS and Science Act, designed to strengthen American semiconductor manufacturing, supply chains and national security.
  • “When I wrote the CHIPS & Science Law, I made sure there was funding especially for the feature-rich, legacy chips that GlobalFoundries produces in Malta and that are essential for America’s auto industry and national defense.
  • “The CHIPS Act funding will help encourage innovation and expansion of this vital sector in our state and across the country.

Purchase College Alumni and Faculty Win Grammy Awards for Jazz and Classical Music

Retrieved on: 
星期二, 二月 6, 2024
Alumni, Tight, How Love Begins, Conservatory, SUNY, Environment, Faculty, Lecturer, Electric Lady Studios, GRAMMY, Student, Grammy Awards, Engineering, Music

PURCHASE, N.Y., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Purchase College, SUNY is excited to announce that alumni and faculty members took home GRAMMY Awards this past weekend.

Key Points: 
  • PURCHASE, N.Y., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Purchase College, SUNY is excited to announce that alumni and faculty members took home GRAMMY Awards this past weekend.
  • Jazz Studies alum Samara Joy '21, who took home two GRAMMY awards last year, has won a third award for Best Jazz Performance for "Tight."
  • Nicole Zuraitis, Lecturer of Jazz Studies, Voice, received the Best Jazz Vocal Album award for her album, How Love Begins.
  • From jazz to classical music, our faculty and alumni of the Conservatory of Music are making great strides.

Brenmiller Successfully Hands Over its First bGen™ Thermal Energy Storage System in the U.S. to State University of New York (SUNY)

Retrieved on: 
星期二, 二月 6, 2024
Alternative Energy, Energy, Partnership, BIRD, SUNY, State university system, Electricity

Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy” or the “Company”) (Nasdaq: BNRG), a global leader in thermal energy storage (“TES”), today announced that it has completed all required system tests and operator training and has handed over its first bGen™ installation in the United States to a State University of New York (SUNY) campus.

Key Points: 
  • Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy” or the “Company”) (Nasdaq: BNRG), a global leader in thermal energy storage (“TES”), today announced that it has completed all required system tests and operator training and has handed over its first bGen™ installation in the United States to a State University of New York (SUNY) campus.
  • The bGen™ storage system installation at a SUNY college charges by using both exhaust gas and electricity and discharges heat on demand.
  • Brenmiller’s bGen™ is expected to eliminate approximately 550 metric tons of greenhouse gas emissions for SUNY annually.
  • Developed and deployed in partnership with the New York Power Authority, the largest state power organization in the U.S., the project was financed in part by a grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

Coursera Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
星期四, 二月 1, 2024
Education, Technology, Software, Artificial Intelligence, Continuing, University, Training, Online, Cloud, Language, Microsoft, Total, Professional, Partnership, Security (finance), Knowledge, ACE, Consumer, Government, Campus, Generative, Google Cloud, Student, Business, University of Prince Mugrin, Growth, SUNY, Banco Santander, Synthetic media, Regulation, American Council, Net income, Free cash flow, Data science, New Yorker, GAAP, Research, AI, College of Charleston, Qatar University, Disclosure, Regulation Fair Disclosure, Ratio, Stanford Online, AWS

Coursera, Inc. (NYSE: COUR) today announced financial results for its fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Coursera, Inc. (NYSE: COUR) today announced financial results for its fourth quarter and full year ended December 31, 2023.
  • “In 2023, we grew revenue 21% year-over-year and delivered positive Adjusted EBITDA for the first time in the fourth quarter,” said Ken Hahn, Coursera’s CFO.
  • We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP financial results included in this press release.
  • As previously announced, Coursera will hold a conference call to discuss its fourth quarter and full year 2023 performance today, February 1, 2024, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Purchase College Professor Awarded Major Grant by New York State's Department of Environmental Conservation

Retrieved on: 
星期四, 二月 1, 2024
Plant, Biophysical environment, Water quality, School, Purchasing, Research, Environmental protection, Environmental studies, SUNY, Teaching, Environment, Tree, EPF, Animal, Natural Resources, Acquisition, Education, Social science, State, Associate, Student, Nature, Nursing

PURCHASE, N.Y., Feb. 1, 2024 /PRNewswire-PRWeb/ -- Purchase College, SUNY, is pleased to announce that Dr. Allyson Jackson, Associate Professor of Environmental Studies, has been awarded a major grant in the amount of $99,480 by New York State's Department of Environmental Conservation to support invasive species prevention.

Key Points: 
  • Dr. Allyson Jackson, Associate Professor of Environmental Studies at Purchase College, has been awarded a major grant in the amount of $99,480 by New York State's Department of Environmental Conservation to support invasive species prevention.
  • PURCHASE, N.Y., Feb. 1, 2024 /PRNewswire-PRWeb/ -- Purchase College, SUNY, is pleased to announce that Dr. Allyson Jackson, Associate Professor of Environmental Studies, has been awarded a major grant in the amount of $99,480 by New York State's Department of Environmental Conservation to support invasive species prevention.
  • The Purchase College grant is one 43 projects awarded a total of $3 million to reduce the negative impacts of invasive species on New York State's natural resources, economy, and communities.
  • Dr. Ryan Taylor, Chair of the Environmental Studies department, said, "The entire Environmental Studies department is eager to start implementing this restoration project.

Brenmiller Signs MOU with RSP Systems to Boost bGen™ ZERO Sales in the U.S.

Retrieved on: 
星期四, 一月 11, 2024
Other Energy, Environment, Utilities, Alternative Energy, Green Technology, Energy, SUNY, Sustainable energy, Natural gas, State university system, State, TES, Electricity, MOU, RSP, Negotiation, GHG, Invention, Renewable energy

Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy” or the “Company”) (Nasdaq: BNRG), a global leader in thermal energy storage (“TES”), today announced it has signed a non-binding Memorandum of Understanding (MOU) with RSP Systems outlining the terms of a distribution agreement.

Key Points: 
  • Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy” or the “Company”) (Nasdaq: BNRG), a global leader in thermal energy storage (“TES”), today announced it has signed a non-binding Memorandum of Understanding (MOU) with RSP Systems outlining the terms of a distribution agreement.
  • Subject to negotiating and execution of definitive agreements, RSP Systems would be the exclusive distributor of bGen™ in the U.S. Northeast Region.
  • RSP Systems has prior experience working with Brenmiller on its first project in the U.S., combining Brenmiller’s TES with a Capstone turbine to reduce GHG emissions and create monetary savings.
  • Cory Glick, RSP Systems’ President commented, “We worked closely with Brenmiller on the bGen™ installation at the State University of New York (SUNY) Purchase campus.